References
- Birgens H S, Espersen F, Hertz J B, Karup Pedersen F, Drivsholm A. Antibody response to pneumococcal vaccination in patients with myelomatosis. Scand J Haematol 1983; 30: 324
- Cone L, Uhr J W. Immunological deficiency disorders associated with chronic lymphocytic leukemia and multiple myeloma. J Clin Invest 1964; 12: 2241
- Fahey J L, Scroggins R, Utz J P, Szwed C F. Infection, antibody response and gamma globulin components in multiple myeloma and macroglobulinemia. Am J Med 1963; 35: 698
- Glenchur H, Zinneman H H, Hall W H. A review of 51 cases of multiple myeloma: emphasis on pneumonia and other infections as complications. Arch Intern Med 1959; 103: 173
- Medical Research Council's Working Party for Therapeutic Trials in Leukemia: Report on the first myelomatosis trial. Br J Haematol 1973; 24: 123
- Meyers B R, Hirschman S Z, Axelrod J A. Current patterns of infection in multiple myeloma. Am J Med 1972; 52: 87
- Perri R T, Hebbel R P, Oken M M. Influence of treatment and response status on infection risk in multiple myeloma. Am J Med 1981; 71: 935
- Paaske Hansen O, Thorling E B, Drivsholm A. Serum erythropoietin in myelomatosis. Scand J Haematol 1977; 19: 106
- Paglieroni T, Mackenzie M R. Studies on the pathogenesis of an immune defect in multiple myeloma. J Clin Invest 1977; 59: 1120
- Savage D G, Lindenbaum J, Garrett T J. Biphasic pattern of bacterial infection in multiple myeloma. Ann Intern Med 1982; 96: 47
- Twomey J J. Infections complicating multiple myeloma and chronic lymphocytic leukemia. Arch Intern Med 1973; 132: 562
- Zinneman H H, Hall W H. Recurrent pneumonia in multiple myeloma and some observations on immunologic response. Ann Intern Med 1954; 41: 1152